Astma kliniske forsøg i Illinois
10 studier for Astma søger deltagere på steder i Illinois.
Byer i Illinois
Officiel studietekst (engelsk)
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
- GSK Investigational Site, Normal
RekruttererFase 3
Alder 12 til 17 · Alle køn · Opdateret 30. sep. 2026 · NCT05757102ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
- Enveda Investigative Site, Maryville
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 24. sep. 2026 · NCT07301255A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
- Axis Clinical Trials - Westchester, Westchester
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 22. sep. 2026 · NCT07219173A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
- Christie Clinic - University, Champaign
- Innovo Research - Christie Clinic, Champaign
- Christie Clinic - Windsor, Champaign
RekruttererFase 2
Alder 18 til 70 · Alle køn · Opdateret 22. sep. 2026 · NCT06977581A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)
- Research Site 31, Glenview
RekruttererFase 3
Alder 12 til 80 · Alle køn · Opdateret 21. sep. 2026 · NCT07276724A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
- Teva Investigational Site 12162, Westchester
RekruttererFase 3
Alder 12 og opefter · Alle køn · Opdateret 31. aug. 2026 · NCT06664619Registry of Asthma Characterization and Recruitment 3 (RACR3)
- Ann & Robert H. Lurie Children's Hospital of Chicago: Division of Allergy and Immunology, Chicago
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alle aldre · Alle køn · Opdateret 21. aug. 2026 · NCT05272241Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
- Research Site, Normal
RekruttererFase 3
Alder 12 til 17 · Alle køn · Opdateret 13. aug. 2026 · NCT06307665A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma
- Research site, Chicago
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 28. jul. 2026 · NCT07532265Protocol CAUSE-03 / CHEETAH
- Ann & Robert H. Lurie Children's Hospital of Chicago: Division of Allergy and Immunology, Chicago
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 6 til 17 · Alle køn · Opdateret 1. jul. 2026 · NCT06136091Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.